No Spotlight Needed

Jeff Park spent over a decade transforming SXC Health Solutions into Catamaran, a pharmacy benefits technology company that sold to UnitedHealthcare for $12.8 billion, a 65 times return on the original investment. He did it through 14 plus acquisitions, a relentless integration playbook, and one core belief: people are the only competitive advantage. In this episode of No Spotlight Needed, Jeff wa...

Some of the best conversations are with the people you think you already know. In this episode of No Spotlight Needed, host Sheetal Mehta Prasad sits down with Dipal Doshi, CEO of Entrada Therapeutics, for an honest look at what it takes to build a biotech company with conviction. Dipal was Entrada's first full-time employee. As a non-scientist, he helped take the company from an unproven hypo...

On paper, SOPHiA GENETICS should not have worked. Jurgi Camblong was not a software engineer or a trained CEO. He was building an AI company in Switzerland in 2011 before AI was a mainstream conversation, raising capital in Europe when most of the money was in the United States, and selling to hospitals that needed years to trust the technology. Fifteen years later, SOPHiA GENETICS supports nearly...

Paul Perreault led CSL for a decade, growing it into a $130 billion market cap company and the world's leading manufacturer of plasma derived therapies. He started as a field sales rep, planned to become a priest, and carried one lesson through his entire career: never confuse your job title with who you are. In this conversation Paul talks about the generalist philosophy that shaped his leade...

Kevin Sayer spent 15 years as CEO of Dexcom, growing it from a niche startup into a $4 billion company that created the continuous glucose monitoring industry from scratch. In this episode of No Spotlight Needed, he sits down with Sheetal to tell the whole story: the early bets, the hard lessons, the bold moves, and what it really took to build something that has saved lives around the world. Kevi...

What does a career look like when one chapter ends with an $11 billion acquisition, the next involves FBI visits and death threats, and the third ends with a devastating phase 3 failure that nobody saw coming? Dr. Michelle Berrey has lived all three. Over 15 years as a chief medical officer and CEO at Pharmasset, Chimerix, and Intercept Pharmaceuticals, she helped develop a cure for hepatitis C, n...

What does it actually take to build a biotech from nothing... no IP, no programs, no money — into a company acquired by Eli Lilly for over $3 billion? In this episode of No Spotlight Needed, host Sheetal sits down with Praveen Tipirneni — engineer, physician, and military-trained biotech CEO who built Morphic Therapeutic over nine years, nearly died from an out-of-hospital cardiac arrest midway th...

Welcome to Season 2 of No Spotlight Needed! Episode 1 features Bruce Cozadd, former CEO of Jazz Pharmaceuticals. Bruce walks through the real moments behind building Jazz into a durable business, including what happened during the 2008 crash, how he thought about culture as the company scaled, why “bet the company” decisions need to be named out loud, and what it looks like to step away after a 20...

In this Episode of No Spotlight Needed, Sheetal sits down with Dorothy Gemmell, a five time Chief Commercial Officer who helped scale multiple high growth healthcare businesses. No Spotlight Needed Website: https://www.nospotlightneeded.com/ Dorothy shares how she went from studying biochemistry at McGill University to pharmaceutical sales, then into leadership at 25, and eventually into the early...

Most people know LabCorp for routine blood work. But under CEO Dave King, the company expanded far beyond basic diagnostics, scaling from about $4B to $14B in revenue while navigating relentless pricing pressure, major acquisitions, and a rapidly changing healthcare landscape. In this conversation, Dave breaks down what it really takes to scale through M&A, why some deals worked and others mis...

Many investors and operators call Mettler Toledo one of the best run companies in the world. In season 1, episode #3 of No Spotlight Needed, Sheetal sits down with Bill Donnelly, longtime CFO of Mettler Toledo, to unpack the leadership habits and cultural systems behind decades of consistent execution. Bill shares how his Jesuit foundation shaped his approach to communication, empathy, and decisio...

In Season 1, episode #2 of No Spotlight Needed, host Sheetal Prasad sits down with Erica Rogers, board director and former CEO, to unpack the real story behind building and leading in MedTech, from her early career at Boston Scientific, to founding startups, navigating a company failure, and scaling Silk Road Medical through the public markets. Erica shares what it’s actually like when a clinical...

In Episode 1 of Season 1 of No Spotlight Needed, Sheetal sits down with Keith Grossman, a four time CEO and MedTech operator known for building and turning around companies through focus, urgency, and team first culture. Keith walks through the arc of his career, including becoming CEO of Thoratec at 35 with the company nearly out of cash, engineering a major merger to secure future technology, le...

Welcome to No Spotlight Needed, a leadership podcast that explores the human stories behind extraordinary executives. Hosted by Sheetal Prasad, an equity investor with 25+ years of experience analyzing business models and assessing management teams, this show goes beyond the surface. These conversations focus on what rarely shows up in headlines or earnings calls: formative moments, values, decisi...